Patents/Assignees

Dana-farber Cancer Institute, Inc.

192 patents in portfolio

US12202904utility2025
IL-23R Antagonists to Reprogram Intratumoral T Regulatory Cells Into Effector Cells
0 cites
US12194055utility2025
Solute Carrier Family 46 Member 3 (SLC46A3) as Marker for Lipid-based Nanoparticle Cancer Therapy and Diagnostics
0 cites
US12194080utility2025
Methods for Identification, Assessment, Prevention, and Treatment of Metabolic Disorders Using PM20D1 and N-lipidated Amino Acids
0 cites
US12195514utility2025
Chimeric Antigen Receptors and Methods of Use Thereof
0 cites
US12195802utility2025
Universal Early Cancer Diagnostics
0 cites
US12187701utility2025
Taire Family Kinase Inhibitors and Uses Thereof
0 cites
US12171783utility2024
Methods and Compositions for Targeting Developmental and Oncogenic Programs in H3K27M Gliomas
0 cites
US12168803utility2024
Compositions and Methods for Screening and Diagnosis of Prostate Cancer
0 cites
US12161649utility2024
Inhibitors of EGFR and Methods of Use Thereof
0 cites
US12161663utility2024
Compositions and Methods for Targeting Cells
0 cites
US12165747utility2024
Molecular Spatial Mapping of Metastatic Tumor Microenvironment
0 cites
US12157738utility2024
Macrocyclic Inhibitors of ALK, TRKA, TRKB, and ROS1
0 cites
US12153051utility2024
Reagents for Quantitative Mass Spectrometry
0 cites
US12146168utility2024
Human CGAS-DNA Complex and Encoded Protein
0 cites
US12146196utility2024
C-RAF Mutants That Confer Resistance to RAF Inhibitors
0 cites
US12139535utility2024
Methods for Upregulating Immune Responses Using Combinations of Anti-rgmb and Anti-pd-1 Agents
0 cites
US12129248utility2024
Chromobox Protein Inhibitors and Uses Thereof
0 cites
US12121521utility2024
Uses of Salt-inducible Kinase (SIK) Inhibitors for Treating Osteoporosis
0 cites
US12123019utility2024
Uses of Kinase Inhibitors for Inducing and Maintaining Pluripotency
0 cites
US12115151utility2024
Method of Treatment of P53 WT Tumors
0 cites

← PreviousPage 5 of 10Next →